@J&J

Johnson & Johnson booster slashed hospitalizations during omicron wave by 85 percent, South Africa study suggests

Nicholas Crisp, deputy director general of the South African National Department of Health, said in the statement that he hoped the data would “reassure healthcare workers who have not taken their booster to get vaccinated as soon as possible.”

The Johnson & Johnson booster could play a key role in cutting coronavirus hospitalizations, according to preliminary results from a South African study that reviewed over 69,000 health-care workers who received a second dose, reports the Washington Post.

The study, which has not yet been peer reviewed, looked at hospital admissions from mid-November to mid-December, as the country experienced a wave of omicron infections, and compared the boosted health-care workers with people who had not been vaccinated. It found that the booster was about 85 percent effective in preventing hospital admissions from covid-19, one to two months after the second dose.

In a statement shared Thursday, Johnson & Johnson said that the preliminary findings demonstrated the booster’s effectiveness in the face of a highly transmissible omicron variant of the virus, which is now dominant in South Africa.

Nicholas Crisp, deputy director general of the South African National Department of Health, said in the statement that he hoped the data would “reassure healthcare workers who have not taken their booster to get vaccinated as soon as possible.”

© Copyright LaPresse

Go to Top